Scientists have way to control sugars that lead to diabetes, obesity

September 26, 2012 by Brian Wallheimer

(Medical Xpress)—Scientists can now turn on or off the enzymes responsible for processing starchy foods into sugars in the human digestive system, a finding they believe will allow them to better control those processes in people with type 2 diabetes and obesity.

Bruce Hamaker, a professor of food science and director of the Whistler Center for Carbohydrate Research at Purdue University, said the four enzymes, called alpha-glucosidases, are responsible for generating from starch digestion. Each functions differently, breaking down starches into different sugars at different rates. Someone missing one or more of those enzymes creates glucose improperly.

Influx of glucose to the blood increases from the pancreas, which allows the body to remove the sugar. When the body's tissues cannot respond well to insulin, the blood sugar is not lowered, a situation seen in type 2 diabetics. Even in non-diabetics, excess sugars not burned by the body as energy may be stored as fat, an issue for people prone to obesity.

"In diabetics, you don't want this roller coaster of blood-glucose levels. Their bodies can't regulate glucose that well," Hamaker said. "If you can selectively inhibit these enzymes, it opens up the possibility of moderating glucose to the body as well as directing glucose release into different parts of the small intestines for certain physiologic responses."

Hamaker and Mario Pinto, professor of chemistry and vice president for research at Simon Fraser University in Vancouver, Canada, members of a starch , led the study. Their results were published in the .

Hamaker's group did the inhibition studies on starch degradation products and the alpha-glucosidase enzymes, provided by other members of the consortium, in a simulated system. The inhibitors, developed in Pinto's laboratory, were able to selectively inhibit the enzymes, a process they have called "toggling," and could lead to several solutions for diabetics or those prone to obesity.

"We could provide the missing enzymes or develop new starches that will digest properly with the enzymes they do have," Pinto said. "It's all about control and using the molecular information we have to control those enzymes."

Hamaker and Pinto said they would next work to understand how the inhibitors control the intestinal enzymes and refine their understanding of when and where the enzymes should be controlled for the best results.

Explore further: Enzyme in saliva helps regulate blood glucose

More information: Modulation of Starch Digestion for Slow Glucose Release through 'Toggling' of Activities of Mucosal α-Glucosidases, Journal of Biological Chemistry.

ABSTRACT
Starch digestion involves the breakdown by α-amylase to small linear and branched malto-oligosaccharides, which are in turn hydrolyzed to glucose by the mucosal α-glucosidases, maltase-glucoamylase (MGAM) and sucrase-isomaltase (SI). MGAM and SI are anchored to the small intestinal brush-border epithelial cells, and each contains a catalytic N- and C-terminal subunit. All four subunits have α-1,4-exohydrolytic glucosidase activity, and the SI N-terminal subunit has an additional exo-debranching activity on the α-1,6-linkage. Inhibition of α-amylase and/or α-glucosidases is a strategy for treatment of type 2 diabetes. We illustrate here the concept of "toggling": differential inhibition of subunits to examine more refined control of glucogenesis of the α-amylolyzed starch malto-oligosaccharides with the aim of slow glucose delivery. Recombinant MGAM and SI subunits were individually assayed with α-amylolyzed waxy corn starch, consisting mainly of maltose, maltotriose and branched α-limit dextrins, as substrate in the presence of four different inhibitors: acarbose and three sulfonium ion compounds. The IC50 values show that the four α-glucosidase subunits could be differentially inhibited. The results support the prospect of controlling starch digestion rates to induce slow glucose release through the toggling of activities of the mucosal α-glucosidases by selective enzyme inhibition. This approach could also be used to probe associated metabolic diseases.

Related Stories

Enzyme in saliva helps regulate blood glucose

April 4, 2012
Scientists from the Monell Center report that blood glucose levels following starch ingestion are influenced by genetically-determined differences in salivary amylase, an enzyme that breaks down dietary starches. Specifically, ...

Anchoring proteins influence glucose metabolism and insulin release

September 4, 2012
Scientists from the United States and Sweden have discovered a new control point that could be important as a drug target for the treatment of diabetes and other metabolic diseases. A-kinase anchoring proteins or AKAPs are ...

Scientists find missing link in regulation of glucose

December 22, 2011
(Medical Xpress) -- A team led by USC neuroscientist Alan Watts identified for the first time a biochemical signal that helps regulate the amount of glucose in the blood.

Recommended for you

Want to win at sports? Take a cue from these mighty mice

July 20, 2017
As student athletes hit training fields this summer to gain the competitive edge, a new study shows how the experiences of a tiny mouse can put them on the path to winning.

'Smart' robot technology could give stroke rehab a boost

July 19, 2017
Scientists say they have developed a "smart" robotic harness that might make it easier for people to learn to walk again after a stroke or spinal cord injury.

Engineered liver tissue expands after transplant

July 19, 2017
Many diseases, including cirrhosis and hepatitis, can lead to liver failure. More than 17,000 Americans suffering from these diseases are now waiting for liver transplants, but significantly fewer livers are available.

Lunatic Fringe gene plays key role in the renewable brain

July 19, 2017
The discovery that the brain can generate new cells - about 700 new neurons each day - has triggered investigations to uncover how this process is regulated. Researchers at Baylor College of Medicine and Jan and Dan Duncan ...

New animal models for hepatitis C could pave the way for a vaccine

July 19, 2017
They say that an ounce of prevention is worth a pound of cure. In the case of hepatitis C—a disease that affects nearly 71 million people worldwide, causing cirrhosis and liver cancer if left untreated—it might be worth ...

Omega-3 fatty acids fight inflammation via cannabinoids

July 18, 2017
Chemical compounds called cannabinoids are found in marijuana and also are produced naturally in the body from omega-3 fatty acids. A well-known cannabinoid in marijuana, tetrahydrocannabinol, is responsible for some of its ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

El_Nose
not rated yet Sep 26, 2012
and the fat pill was born in early 2013. It revolutionized industrial nations. As people no longer developed good self control this led to down falls in other areas. But most noticeable was the rise of the buffet style McDonald's and its cementing controlling market share of the fast food industry by being first deliver the buffet of an already popular food source.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.